Intragam P (intravenous normal human immunoglobulin) / CSL Behring - LARVOL DELTA

Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukaemia patients with hypogammaglobulinaemia and infection. (PubMed, Eur J Haematol) - "This study provides a globally unique insight into IgRT supply and demand in CLL patients by analysis of total national use in Australia over a six year period."

Journal • Chronic Lymphocytic Leukemia • Hematological Malignancies • Infectious Disease • Leukemia • Oncology

Intragam 10 Adverse Reactions: Is Pharmacovigilance Enough? (HAA 2017) - "Conclusion The increased concentration of the new Intragam 10 product appears to be the cause of the developed symptoms. In 82% of patients, the introduction of pre-hydration prior to the infusion +/- a 2:1 Normal Saline/ Intragam 10 ratio was sufficient in preventing the adverse reactions occurring."

Adverse events • Clinical • Biosimilar • Pain